Literature DB >> 951139

Syndrome of intrahepatic biliary dysgenesis and cardiovascular malformations.

R D Greenwood, A Rosenthal, A C Crocker, A S Nadas.   

Abstract

Peripheral pulmonary stenosis with or without intracardiac disease is described in 14 patients with intrahepatic biliary dysgenesis. Cardiovascular malformations were not present among a large group of patients with extrahepatic biliary dysgenesis. This association of intrahepatic biliary dysgenesis and vascular malformations is postulated to be a specific malformation syndrome resulting most probably from intrauterine infection. The cardiovascular disease is usually mild. The liver dysfunction varies in severity, and is accompanied by a notable hyperlipoproteinemia with secondary xanthomata which can be ameliorated by long-term treatment with cholestyramine resin and/or vegetable oil supplements.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 951139

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  13 in total

Review 1.  Alagille syndrome: pathogenesis, diagnosis and management.

Authors:  Peter D Turnpenny; Sian Ellard
Journal:  Eur J Hum Genet       Date:  2011-09-21       Impact factor: 4.246

2.  Alagille syndrome: family studies.

Authors:  F V Elmslie; A J Vivian; H Gardiner; C Hall; A P Mowat; R M Winter
Journal:  J Med Genet       Date:  1995-04       Impact factor: 6.318

Review 3.  Alagille syndrome.

Authors:  I D Krantz; D A Piccoli; N B Spinner
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

Review 4.  Alagille's syndrome associated with cystic renal disease.

Authors:  S R Martin; L Garel; F Alvarez
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

5.  Balloon pulmonary valvuloplasty and stent implantation. For peripheral pulmonary artery stenosis in Alagille syndrome.

Authors:  A S Saidi; J P Kovalchin; D J Fisher; G D Ferry; R G Grifka
Journal:  Tex Heart Inst J       Date:  1998

Review 6.  Neonatal obstructive cholangiopathy.

Authors:  D K Bhasin; S Mehta
Journal:  Indian J Pediatr       Date:  1984 Jan-Feb       Impact factor: 1.967

7.  Arteriohepatic dysplasia: a 16-year follow-up during treatment with cholestyramine.

Authors:  A L Flick
Journal:  West J Med       Date:  1982-01

Review 8.  The Alagille syndrome (arteriohepatic dysplasia).

Authors:  R F Mueller
Journal:  J Med Genet       Date:  1987-10       Impact factor: 6.318

9.  Biliary tract abnormalities in patients with arteriohepatic dysplasia.

Authors:  F S Gorelick; J W Dobbins; M Burrell; C A Riely
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

10.  Glomerular mesangiolipidosis in Alagille syndrome (arteriohepatic dysplasia).

Authors:  R Habib; J P Dommergues; M C Gubler; M Hadchouel; M Gautier; M Odievre; D Alagille
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.